FDA Adverse Event Other Summary report: N

1030451-2012-00003

MDR report key: 3118742 · Received June 7, 2012

Report

Report Number
1030451-2012-00003
Event Type
Other
Date Received
June 7, 2012
Product Code
LRS
Report Source
Manufacturer report

Narratives

Additional Manufacturer Narrative · 1

ON 05/31/2012, MEDICAL ACTION INDUSTRIES (MAI) (B)(4) FACILITY RECEIVED FROM THE FDA, A COPY MEDWATCH REPORT WHICH WAS THEN FORWARDED TO MAI COMPLAINT UNIT (B)(4). MAI HAD PREVIOUSLY RECEIVED THIS COMPLAINT ON 05/23/2012 AND HAD ASSIGNED COMPLAINT # (B)(4). (B)(6) WAS CONTACTED IMMEDIATELY FOR FURTHER INFO AND RGA #(B)(4) AND (B)(4) LABEL TRACKING WERE ISSUED TO (B)(6) TO RETURN THE COMPLAINED CHLORAPREP TO OUR (B)(4) FACILITY. MAI CONTACTED CAREFUSION THE MFR OF THE COMPLAINED CHLORAPREP AND ISSUED SCAR # (B)(4), CAREFUSION ISSUED COMPLAINT # (B)(4). THE COMPLAINED CHLORAPREP SAMPLE WAS RECEIVED AT OUR (B)(4) FACILITY ON 06/06/2012 AND IMMEDIATELY SHIPPED OVERNIGHT TO: CAREFUSION, ATTN. (B)(4) - FRONT DESK. CAREFUSION'S RESPONSE TO SCAR # (B)(4) WILL BE REVIEWED AND KEPT ON FILE ONCE RECEIVED. IN ADDITION, THIS OCCURRENCE HAS BEEN ENTERED INTO MAI'S FORMAL COMPLAINT SYSTEM IN WHICH DEFECT TRENDS ARE CLOSELY MONITORED.

Description of Event or Problem · 1

(B)(4).

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 LRS

Patients

Seq Age Sex Outcome Treatment
1